387 related articles for article (PubMed ID: 19552926)
1. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.
Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H
J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926
[TBL] [Abstract][Full Text] [Related]
2. Voxel-based analysis of amyloid positron emission tomography probe [C]BF-227 uptake in mild cognitive impairment and alzheimer's disease.
Shao H; Okamura N; Sugi K; Furumoto S; Furukawa K; Tashiro M; Iwata R; Matsuda H; Kudo Y; Arai H; Fukuda H; Yanai K
Dement Geriatr Cogn Disord; 2010; 30(2):101-11. PubMed ID: 20733303
[TBL] [Abstract][Full Text] [Related]
3. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
[TBL] [Abstract][Full Text] [Related]
4. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
[TBL] [Abstract][Full Text] [Related]
5. Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
Furukawa K; Okamura N; Tashiro M; Waragai M; Furumoto S; Iwata R; Yanai K; Kudo Y; Arai H
J Neurol; 2010 May; 257(5):721-7. PubMed ID: 19946781
[TBL] [Abstract][Full Text] [Related]
6. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
Koivunen J; Scheinin N; Virta JR; Aalto S; Vahlberg T; Någren K; Helin S; Parkkola R; Viitanen M; Rinne JO
Neurology; 2011 Mar; 76(12):1085-90. PubMed ID: 21325653
[TBL] [Abstract][Full Text] [Related]
7. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
[TBL] [Abstract][Full Text] [Related]
8. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
Okello A; Koivunen J; Edison P; Archer HA; Turkheimer FE; Någren K; Bullock R; Walker Z; Kennedy A; Fox NC; Rossor MN; Rinne JO; Brooks DJ
Neurology; 2009 Sep; 73(10):754-60. PubMed ID: 19587325
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
[TBL] [Abstract][Full Text] [Related]
10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
11. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
Hatashita S; Yamasaki H
J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O;
Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247
[TBL] [Abstract][Full Text] [Related]
13. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
14. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
Hatashita S; Wakebe D
J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
17. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
19. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
20. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
